While the majority of the Herpes Simplex Virus (HSV) treatment market focuses on managing genital and oral lesions, specialized, high-stakes segments exist for severe manifestations, particularly **herpes simplex keratitis (ocular HSV)** and **neonatal HSV infection**. Ocular HSV is a leading cause of infectious blindness globally, requiring highly targeted and aggressive therapy to prevent...